Adami S - Search Results

1

Bone loss in response to long-term glucocorticoid therapy.

LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, DellaRocca C. LoCascio V, et al. Among authors: adami s. Bone Miner. 1990 Jan;8(1):39-51. doi: 10.1016/0169-6009(91)90139-q. Bone Miner. 1990. PMID: 2306553

2

The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.

Adami S, Fossaluzza V, Rossini M, Bertoldo F, Gatti D, Zamberlan N, Lo Cascio V. Adami S, et al. Bone Miner. 1991 Oct;15(1):73-81. doi: 10.1016/0169-6009(91)90111-c. Bone Miner. 1991. PMID: 1747568 Clinical Trial.

3

Transdermal estradiol in the treatment of postmenopausal bone loss.

Adami S, Suppi R, Bertoldo F, Rossini M, Residori M, Maresca V, Lo Cascio V. Adami S, et al. Bone Miner. 1989 Aug;7(1):79-86. doi: 10.1016/0169-6009(89)90064-0. Bone Miner. 1989. PMID: 2670019 Clinical Trial.

4

Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

Adami S, Mian M, Gatti P, Rossini M, Zamberlan N, Bertoldo F, Lo Cascio V. Adami S, et al. Bone. 1994 Jul-Aug;15(4):415-7. doi: 10.1016/8756-3282(94)90818-4. Bone. 1994. PMID: 7917580 Clinical Trial.

5

Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.

Adami S, Zamberlan N, Mian M, Dorizzi R, Rossini M, Braga B, Gatti D, Bertoldo F, Locascio V. Adami S, et al. Bone Miner. 1994 May;25(2):75-82. doi: 10.1016/s0169-6009(08)80249-8. Bone Miner. 1994. PMID: 8086853

6

The effects of menopause and estrogen replacement therapy on the renal handling of calcium.

Adami S, Gatti D, Bertoldo F, Rossini M, Fratta-Pasini A, Zamberlan N, Facci E, Lo Cascio V. Adami S, et al. Osteoporos Int. 1992 Jul;2(4):180-5. doi: 10.1007/BF01623924. Osteoporos Int. 1992. PMID: 1611223

7

The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.

Adami S, Bolzicco GP, Rizzo A, Salvagno G, Bertoldo F, Rossini M, Suppi R, Lo Cascio V. Adami S, et al. Bone Miner. 1987 Aug;2(5):395-404. Bone Miner. 1987. PMID: 2975514

8

Intramuscular administration of salmon calcitonin impairs delayed cutaneous hypersensitivity.

Adami S, Suppi R, Residori M, Braga V, Zamboni M, LoCascio V. Adami S, et al. Bone Miner. 1988 Apr;4(1):91-4. Bone Miner. 1988. PMID: 3191274

9

Bone loss after glucocorticoid therapy.

Lo Cascio V, Bonucci E, Imbimbo B, Ballanti P, Tartarotti D, Galvanini G, Fuccella L, Adami S. Lo Cascio V, et al. Among authors: adami s. Calcif Tissue Int. 1984 Jul;36(4):435-8. doi: 10.1007/BF02405356. Calcif Tissue Int. 1984. PMID: 6435841 No abstract available.

10

Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.

Lo Cascio V, Kanis JA, Beneton MN, Bertoldo F, Adami S, Poggi G, Zanolin ME. Lo Cascio V, et al. Among authors: adami s. Calcif Tissue Int. 1995 Feb;56(2):109-12. doi: 10.1007/BF00296340. Calcif Tissue Int. 1995. PMID: 7736317 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters